Related Experiment Video
Updated: May 24, 2026
07:47
Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
Published on: September 15, 2023
AI in multi-omics analysis in cancer.
Koushikee Ghosh1, Suditi Saha2, Sudipto Saha1
1Department of Biological Sciences, Bose Institute, Kolkata, India.
Summary
Multi-omics integration is crucial for understanding cancer recurrence and drug resistance in major cancers like lung, breast, colorectal, and prostate. This approach aids in developing artificial intelligence (AI) models for improved cancer prediction and patient outcomes.
Area of Science:
- Oncology
- Bioinformatics
- Computational Biology
Background:
- Increasing global prevalence of lung, breast, colorectal, and prostate cancers.
- Cancer recurrence and drug resistance remain significant clinical challenges.
- Multi-omics data integration offers potential for advancing cancer research.
Purpose of the Study:
- To review multi-omics resources for cancer data reanalysis.
- To discuss the development of AI-based prediction models using multi-omics data.
- To explore multi-omics integration in major cancer types.
Main Methods:
- Review of multi-omics integration approaches.
- Discussion of artificial intelligence (AI) and statistical methods for data analysis.
- Focus on integrating diverse biological data types (genomics, transcriptomics, etc.).
Main Results:
- Multi-omics integration is effective for cancer sub-classification.
- These approaches enhance prediction of patient survival and recurrence.
- AI-based models show promise in cancer prediction.
Conclusions:
- Multi-omics integration is vital for addressing cancer recurrence and drug resistance.
- Available resources facilitate the development of advanced AI prediction models.
- Further research in multi-omics integration will improve cancer management and patient outcomes.
